Everything below concerns GLP-1. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-10-31. Where a claim depends on a specific study, the study is described rather than over-claimed.
Native GLP-1 is degraded rapidly by dipeptidyl peptidase-4. Semaglutide resists this cleavage because alanine at position 8 is replaced by alpha-aminoisobutyric acid. A second substitution at position 34 introduces arginine, which further stabilizes the peptide. The most distinctive modification is a spacer and C18 fatty diacid attached at lysine 26, enabling strong albumin affinity. These three changes together produce a half-life measured in days rather than minutes, and the same structural logic underlies other long-acting analogs in this class.
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1, a hormone released from intestinal L-cells after food intake. It contains 31 amino acids and differs from native GLP-1 through modifications that slow enzymatic breakdown. The peptide was developed to extend the short circulating half-life of endogenous GLP-1, which is measured in minutes. Researchers introduced the compound in the early 2010s. Two backbone changes and a fatty acid side chain define its structure, distinguishing it from earlier GLP-1 receptor agonists.
The compound binds the GLP-1 receptor on pancreatic beta cells and other tissues, activating a G-protein signaling cascade that raises intracellular cyclic AMP. This action increases glucose-dependent insulin secretion when blood glucose is elevated, while binding also slows gastric emptying and reduces glucagon release. In the central nervous system, receptor activation in the hypothalamus and brainstem contributes to reduced appetite. The fatty acid chain binds albumin, which protects the peptide from renal filtration and enzymatic degradation. This albumin binding is central to its extended circulation time.
Activation of the GLP-1 receptor couples to Gs signalling and raises intracellular cyclic AMP in pancreatic beta cells. The resulting insulin release depends on prevailing glucose concentrations, so the effect is greater when glucose is elevated. Receptor engagement also suppresses glucagon secretion and slows gastric emptying, which flattens post-meal glucose excursions. In the central nervous system, signalling in hypothalamic and brainstem regions is associated with reduced appetite and lower energy intake. Studies continue to examine effects on cardiac, renal and hepatic endpoints; whether those benefits are independent of weight change remains an open question.
Clinical development of this compound followed earlier short-acting GLP-1 analogues that required frequent injection. Once-weekly subcutaneous formulations entered use after 2017, and an oral formulation using a permeation enhancer later became available. The oral version pairs the peptide with sodium N-(8-[2-hydroxybenzoyl] amino) caprylate, a carrier that improves uptake across the gastric epithelium. Interest has expanded from glycaemic control into weight management and metabolic liver disease. Regulatory status and approved indications differ between countries, and the product remains subject to ongoing safety monitoring.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | 31 amino acids |
| Backbone modification | Aib at position 8 | Blocks DPP-4 cleavage |
| Fatty acid chain | C18 diacid | Supports albumin binding |
| Native half-life | 1 to 2 minutes | Endogenous GLP-1 |
| Analog half-life | Approximately one week | Extended by albumin binding |
Certificate of analysis documents from suppliers typically report purity by chromatographic area, water content, and counter-ion identity. Independent verification is advisable because reported values can be generated under differing conditions. Impurity profiles matter for research use, where aggregates, deamidation products, and residual solvents may influence experimental results. Container, lot, and chain-of-custody records support traceability. Analytical results are method-dependent, so comparisons between laboratories require the same procedure and reference standards.
Lyophilized peptide material is typically stored at or below -20 °C, with -80 °C used for longer-term archives. Vials should remain sealed and desiccated because moisture promotes aggregation and hydrolysis. Repeated freeze-thaw cycles are avoided since they can alter peptide conformation and reduce recovery. Once reconstituted, solutions are generally kept at 2-8 °C and used within a defined window. Stability beyond those windows depends on buffer composition and concentration, and exact limits are product-specific rather than universal.
The primary target is the GLP-1 receptor, a class B G protein-coupled receptor expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises intracellular cyclic AMP, which potentiates glucose-dependent insulin secretion and lowers glucagon release when blood glucose is elevated. Signalling in the hypothalamus and brainstem is associated with reduced appetite and slower gastric emptying. Because the insulinotropic effect depends on prevailing glucose levels, the hypoglycaemic risk of the peptide alone is described as low in most study settings. The relative contribution of peripheral and central actions remains an active research question.
Large randomised trials in adults with type 2 diabetes and in adults with obesity have reported reductions in body weight and improvements in several cardiovascular risk markers. One outcome trial found a lower incidence of major adverse cardiovascular events in participants with diabetes and established cardiovascular disease. Gastrointestinal effects such as nausea and vomiting are the most frequently reported adverse events and often diminish over time. Changes in lean body mass during weight loss are an area of ongoing investigation. Effects in adolescents and in pregnancy are less well characterised, and current labelling advises against use during pregnancy.
Although the disease process tends to be slowly progressive over decades, it usually remains asymptomatic until an atheroma ulcerates, leading to immediate blood clotting at the site of the atheroma ulcer. This triggers a cascade of events that leads to clot enlargement, which may quickly obstruct blood flow. A complete blockage leads to ischemia of the myocardial (heart) muscle and damage. This process is the myocardial infarction or "heart attack". If the heart attack is not fatal, fibrous organization of the clot within the lumen ensues, covering the rupture but also producing stenosis or closure of the lumen, or over time and after repeated ruptures, resulting in a persistent, usually localized stenosis or blockage of the artery lumen. Stenoses can be slowly progressive, whereas plaque ulceration is a sudden event that occurs specifically in atheromas with thinner/weaker fibrous caps that have become "unstable". Repeated plaque ruptures, ones not resulting in total lumen closure, combined with the clot patch over the rupture and healing response to stabilize the clot, are the process that produces most stenoses over time. The stenotic areas often become more stable despite increased flow velocities at these narrowings. Most major blood-flow-stopping events occur at large plaques, which, before their rupture, produced little, if any, stenosis. From clinical trials, 20% is the average stenosis at plaques that subsequently rupture, with resulting complete artery closure. Most severe clinical events do not occur at plaques that produce high-grade stenosis.
Étude basée en partie sur les spécimens recueillis par la Calypso". Annales de l'Institut Océanographique. 45: 233–254. Vink DL, von Cosel R (1985). "The Conus cedonulli complex: Historical review, taxonomy and biological observations". Revue suisse de Zoologie. 92: 525–603. doi:10.5962/bhl.part.81894.
Sputnik V (Russian: Спутник V, the brand name from the Russian Direct Investment Fund or RDIF) or Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, the name under which it is legally registered and produced) is an adenovirus viral vector vaccine for COVID-19 developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia. It is the world's first registered combination vector vaccine for the prevention of COVID-19, having been registered on 11 August 2020 by the Russian Ministry of Health. Gam-COVID-Vac was initially approved for distribution in Russia and then in 59 other countries (as of April 2021) on the preliminary results of Phase I–II studies eventually published on 4 September 2020. Approval in early August of Gam-COVID-Vac was met with criticism in mass media and discussions in the scientific community as to whether approval was justified in the absence of robust scientific research confirming safety and efficacy. A large-scale Brazilian study from Dec. 2020 to May 2021 confirmed its effectiveness and safety, as of Oxford–AstraZeneca's, i.e. above Sinopharm BIBP's. Emergency mass-distribution of the vaccine began in December 2020 in countries including Russia, Argentina, Belarus, Hungary, Serbia, Pakistan (in limited quantities), the Philippines (in limited quantities), and the United Arab Emirates. As of 2021 the Sputnik V is registered and certified in 71 countries. However, as of April 2022 less than 2.5% of the people vaccinated worldwide have taken a Sputnik V dose.
== Analysis of cellular organization == Several approaches have been developed to analyze the location of organelles, genes, proteins, and other components within cells. A gene ontology category, cellular component, has been devised to capture subcellular localization in many biological databases.
Sources: en.wikipedia.org
== History of method == The bacteria one-hybrid system has undergone numerous modifications since its inception in 2005. It ultimately arose as a variation of the bacteria two-hybrid system, conceived in 2000, which itself was inspired by the yeast one- and two-hybrid systems. Whereas the two-hybrid versions can assess both protein–protein interaction and protein–DNA interactions, the one-hybrid system specializes in the latter. Meng et al.’s B1H system differs from the two-hybrid version in two key respects. It uses a randomized prey library consisting of many (<2×108) unique potential target sequences and also adds a negative selection step in order to purge this library of self-activating clones. Although these ideas were borrowed from the original yeast one-hybrid system, they had not yet been applied to a bacterial host before 2005. As the technique grew in popularity, researchers amended their protocols to improve the B1H system. Designing the fusion construct (bait) to the omega, rather than the alpha, subunit of RNA polymerase has recently been favoured in order to improve the chimera’s stereochemistry and dynamic range. A zinc-finger domain on the fusion construct and its corresponding DNA target site, adjacent to the randomized prey sequence, has also been added to the increases affinity and specificity of protein–DNA interactions. This increased overall binding affinity allows for the characterization of even those DNA-binding domain proteins which interact weakly with a target sequence.
Per- and polyfluoroalkyl substances (PFAS or PFASs) are a group of synthetic organofluorine chemical compounds that have multiple fluorine atoms attached to an alkyl chain. Because of their high chemical and thermal stability, these compounds have long environmental lifetimes, and thus are commonly called "forever chemicals". The first PFAS, polychlorotrifluoroethylene, was synthesized in 1934. Their widespread use began in 1938 with the invention of Teflon (polytetrafluoroethylene), a fluoropolymer coating that resists heat, oil, stains, grease, and water. Since their inception, thousands of PFAS compounds have been created. They are used in a wide variety of products including waterproof fabric, yoga pants, carpets, shampoo, mobile phone screens, wall paint, furniture, adhesives, food packaging, firefighting foam, electrical insulation, and cosmetics. PFAS are often found in groundwater, wastewater and soil; wastewater treatment facilities and landfills have the highest levels of pollution. Furthermore, crop uptake of PFAS and bioaccumulation of PFAS into fish, livestock, and wildlife can act as potential routes of human exposure. In addition, areas near airports and air force bases are contaminated from the use of PFAS-containing firefighting foam.
== Academic career == After completing his PhD, he worked as a physicist at Bell Laboratories and Columbia University. In 1960, he became a professor of physics at University of California San Diego. Feher died in 2017, aged 93.
Chromatography is a 2004 post trip-hop album by Second Person. This is the band's debut album and all songs were written by Julia Johnson and Mark Maclaine, except "Word for Word" which also credits Ed Webber and Tristan Kajanus, "Demons Die" which also credits Álvaro López and "Divine" which was written by Julia Johnson. The album was recorded, produced and mixed by Mark Maclaine (aka The Silence) at The Silence Corporation Studios, London. The songs "I Spy" and "My Baby Only Cares For Me" were originally written for the 2003 ski/snowboard film: Snow's in the House 2 and they can be found as earlier incarnations on the film's soundtrack.
White tried to use taking more pictures as an excuse to stay out longer, and McDivitt had to coax him in. He finally came back in after a total of approximately 23 minutes, almost 10 minutes later than was planned. He said: "It's the saddest moment of my life." By the time he got in, the spacecraft had entered darkness. The hatch proved to be as stubborn to relatch as it was to open. This would have been disastrous, resulting in both men's deaths on reentry. McDivitt was able to fix the mechanism once again, so White could close it, about 20 minutes after he got in. The mission plan called for opening the hatch again to throw out White's now-unnecessary EVA equipment, but McDivitt elected not to do this, instead keeping the unnecessary equipment on board for the rest of the flight. They powered down the spacecraft's maneuvering system, intending to drift for the next two-and-a-half days to conserve the remaining fuel. They also intended to sleep alternate four-hour periods, but this turned out to be extremely difficult with the constant radio communications and the small cabin, about the size of the front seats of a compact car. White's 20-minute space walk was the mission's highlight, with McDivitt's photographs being published worldwide. These also showed White wearing an Omega Speedmaster chronograph watch on his spacesuit sleeve, one of two makes which had been approved by NASA for space use following extensive tests. Omega were unaware of these tests or the fact that its product was going to be used in space, until the photos.
Sources: en.wikipedia.org
Nuclides (or nucleides, from nucleus; also known as nuclear species) are a class of atoms characterized by their number of protons, Z, their number of neutrons, N, and their nuclear energy state. The word nuclide was coined by the American nuclear physicist Truman P. Kohman in 1947. Kohman defined nuclide as a "species of atom characterized by the constitution of its nucleus" containing a certain number of neutrons and protons. The term thus originally focused on the nucleus.
== Television presenter == In an overview of the broadcasting organisations Galloway works for, Tom Rogan in the National Review in April 2014 described him as being "a Western puppet for tyranny's propagandists". In August 2009, editions of Galloway's programmes The Real Deal and Comment programme for Press TV, a London-based news channel controlled by the government of Iran, were found by the British broadcasting regulator Ofcom to have breached its broadcasting code on impartiality. After Press TV lost its Ofcom licence in 2012, according to Galloway, the Iranian broadcaster owed him £40,000, leading to his company Miranda Media entering compulsory liquidation in 2013 because of unpaid tax. Reportedly, the owed payment amounts to £100,000, although Galloway disputed this in February 2016. Miranda Media, in which income from Galloway's media work was deposited, was established in September 2007 under a month before a law came into force allowing directors to receive loans from their own companies, a facility Galloway used on multiple occasions. Shortly after its foundation in June 2012, Galloway became a presenter with the Al Mayadeen television station where he presents "Kalima Hurra" (Arabic: كلمة حرّة meaning free word). Al Mayadeen reportedly has connections with Iran and the Assad government in Syria, and has been accused of supporting the Assad government, a claim Galloway has rejected. In November 2013, Galloway and his wife Gayatri began to present Sputnik for the Russian government-backed station RT. He is a regular contributor to RT's other programming.
== Nutritional profile == The nutritional profiles of edible insects are highly variable given the large number of species consumed. In addition to species differences, nutritional content can be affected by geographic origin and production method (wild or farmed), diet, age, development stage, and sex. For instance, female house crickets (Acheta domestica) contain more fat than males, while males contain more protein than females. Some insects (e.g. crickets, mealworms) are a source of complete protein and provide similar essential amino acid levels as soybeans, though less than casein. They have dietary fiber, essential minerals, vitamins such as B12, riboflavin and vitamin A, and include mostly unsaturated fat. Locusts contain between 8 and 20 milligrams of iron for every 100 grams of raw locust, whereas beef contains roughly 6 milligrams of iron in the same amount of meat. Crickets are also very efficient in terms of nutrients. For every 100 grams of substance crickets contain 12.9 grams of protein, 121 calories, and 5.5 grams of fat. Beef contains more protein, containing 23.5 grams in 100 grams of substance, but also has roughly triple the calories and four times the amount of fat as crickets do in 100 grams.
=== Medications that cause or worsen myasthenia gravis === Antibiotics: In the macrolide family of antibiotics, azithromycin, telithromycin (which is no longer available in the U.S. market), and erythromycin are reported to exacerbate myasthenia gravis. In the fluoroquinolone antibiotic family, ciprofloxacin, norfloxacin, ofloxacin, and moxifloxacin are reported to exacerbate myasthenia gravis. And, In the aminoglycoside family of antibiotics, gentamicin, streptomycin, and neomycin are reported to exacerbate myasthenia gravis. The aminoglycoside tobramycin has not been reported to exacerbate myasthenia gravis and may be used in people that require aminoglycoside treatment. Because of the rarity or absent reports on their exacerbation of myasthenia gravis, the following antibiotics are considered safe to use in people with myasthenia gravis: the cephalosporin class of drugs, sulfa drugs, the tetracycline group of drugs, clindamycin, polymyxin B, and nitrofurantoin. Immune checkpoint inhibitors: Immune checkpoint inhibitors promote certain types of autoimmune responses by blocking checkpoint pathways that inhibit these responses. They are used to treat cancers that promote their own growth and spread by stimulating checkpoint pathways. These checkpoint inhibitors include pembrolizumab, nivolumab, ipilimumab, avelumab, atezolizumab, and durvalumab. From a total 5,898 people who received these drugs, 52 developed new onset myasthenia gravis and 11 had a flare of their preexisting myasthenia gravis.
Sources: en.wikipedia.org
It is a synthetic analog of GLP-1 produced through medicinal chemistry to resist enzymatic degradation. The design goal was longer circulation than the native hormone.
A fatty acid side chain attaches the peptide to serum albumin, which shields it from kidney filtration and protease activity. This interaction is the main reason its circulation time is extended.
No. The native hormone is GLP-1, and semaglutide is an engineered variant with three deliberate structural alterations. It does not appear in unmodified biological sources.
It belongs to the incretin mimetic class and acts as a long-acting glucagon-like peptide-1 receptor agonist. The class includes several peptides with different half-lives and routes of administration.